Eszopiclone
Product Images NDC 45865-829

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eszopiclone (NDC 45865-829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp-828-30 (828 30)

Packaging label for Eszopiclone Tablets 3 mg, a generic version of Lunesta. The label shows a 30-count package with dose and presentation details. The tablets are dark blue, round, and film-coated, each containing 3 mg of eszopiclone. The labeler is Medsource Pharmaceuticals, with manufacturing by Sun Pharma in Dadra, India. The label includes warnings about possible dry mouth, dizziness, and drowsiness.*

FDA Label Image

Pdp-829-60 (829 60)

ESZOPICLONE Tablets 2 mg box label, generic for Lunesta, containing 60 white round tablets. The label includes dosage strength, product count, and warnings about dry mouth, dizziness, and drowsiness in English and Spanish. The labeler is Medsource Pharmaceuticals. Additional peel here tabs appear on the label's right side for lot and expiration details.*

FDA Label Image

Pdp-830-60 (830 60)

ESZOPICLONE TABLETS 1 MG packaging label showing a 60-count supply. The generic drug for Lunesta is manufactured by Medsource Pharmaceuticals. The label includes NDC 45865-0830-60, with a blue and white film-coated tablet. Warnings about possible dry mouth, dizziness, and drowsiness are provided in English and Spanish. Instructions to take the tablet at bedtime are also included.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of Eszopiclone, illustrating its molecular composition with distinct ring systems and functional groups, including a chlorine-substituted pyridine and a piperazine moiety, consistent with the active ingredient Eszopiclone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.